Flu

The Pharmacy Times® Flu resource center provides information about early symptoms of the flu and the array of therapies in development intended to treat it as it progresses. Additionally, learn more about the data coming directly from the most widely attended pharmacy conferences and meetings, updated clinical trial listings, and other resources.

Beyond the Bench: Advancing Vaccine Education
What can we help you find?
[[thumbnail_alt_text]]
A thorough understanding of immunization billing processes for Medicare, Medicaid, and other third-party payers will be critical to ensure pharmacy staff can efficiently serve their communities and facilitate a smooth reimbursement process.
[[thumbnail_alt_text]]
Learn how you and your staff can help patients differentiate between common cough/cold symptoms and COVID-19 while also offering additional educational resources.
[[thumbnail_alt_text]]
Baloxavir marboxil and oseltamivir are options for treating uncomplicated influenza.
[[thumbnail_alt_text]]
Direct-to-consumer COVID-19 kit allows for anyone over 18 years of age to perform a nasal swab on themselves and send the sample off for testing. 

 
[[thumbnail_alt_text]]
A flu vaccine is especially important this year, as it can prevent a “twindemic” with COVID-19.
 
[[thumbnail_alt_text]]
Proteases are important to the health and viability of cells and viruses. If proteases are inhibited, cells cannot perform many important functions, such as replication.
[[thumbnail_alt_text]]
Further, the findings suggest that cancer survivors are also likely to be at an increased risk of severe coronavirus disease 2019 (COVID-19) outcomes, given that both influenza and COVID-19 are both epidemic respiratory viruses.
[[thumbnail_alt_text]]
Warning letters requested that companies immediately stop selling these unapproved products and said consumers concerned about COVID-19 should talk to their health care provider.
 
[[thumbnail_alt_text]]
Patients with COVID-19 faced a significant emotional and financial burden after discharge from treatment. 
 
[[thumbnail_alt_text]]
Educating Patients on the Correct Use of Treatments Can Lower the Risk of Influenza Complications and Severity
[[thumbnail_alt_text]]
Originally approved in 2018, baloxavir marboxil is indicated for patients aged 12 years and older.
[[thumbnail_alt_text]]
In the midst of a pandemic, visibility and interoperability have never been more critical when it comes to medication inventory.